AOD-9604 minimizes systemic effects by not interacting with growth hormone receptors, in contrast to human growth hormone, from which it is produced
Both are clinically supported, but they work through entirely different mechanisms
Its a quick jab in the upper arm, with minimal discomfort
A healthcare provider will assess suitability
AOD 9604, by contrast, operates in a much more modest range
The most commonly reported side effects are mild and transient: injection site redness or minor bruising, transient fatigue in the first one to two weeks, and occasionally mild headache following the first few injections, a pattern sometimes attributed to the acute shift in cellular energy metabolism as AMPK pathways are upregulated [3]